Processa Pharmaceuticals, Inc. — Director's Dealing 2020

Oct 14, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2020-10-02

Reporting Person: BESSER JAMES E (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	375000	Direct
Common Stock	1125000	Indirect

Footnotes

F1: The reported securities are directly owned by Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P. The reported securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC.

F2: The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.